$771 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 65.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICLR | Sell | ICON PLC | $34,672,000 | -46.7% | 160,000 | -40.2% | 4.50% | -41.9% |
| HQY | Sell | HEALTHEQUITY INC | $29,807,000 | -9.2% | 485,541 | -0.3% | 3.86% | -1.0% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $11,964,000 | -77.4% | 150,000 | -70.2% | 1.55% | -75.4% |
| SGRY | Sell | SURGERY PARTNERS INC | $7,756,000 | -64.8% | 268,176 | -33.0% | 1.01% | -61.6% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $4,961,000 | -66.3% | 1,100,000 | -45.0% | 0.64% | -63.3% |
| Sell | SOMALOGIC INC | $4,520,000 | -68.2% | 1,000,000 | -43.5% | 0.59% | -65.3% | |
| STXS | Sell | STEREOTAXIS INC | $3,140,000 | -50.8% | 1,706,688 | -0.3% | 0.41% | -46.4% |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -300,000 | -100.0% | -1.74% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -130,000 | -100.0% | -2.23% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -1,089,677 | -100.0% | -2.50% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -50,000 | -100.0% | -2.59% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -722,395 | -100.0% | -2.99% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -136,313 | -100.0% | -3.61% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -100,000 | -100.0% | -3.97% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -190,073 | -100.0% | -4.06% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -480,000 | -100.0% | -4.39% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -110,000 | -100.0% | -4.57% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -562,833 | -100.0% | -4.84% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -392,663 | -100.0% | -5.18% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -90,014 | -100.0% | -5.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.